Efficacy and safety of a new immunoglobulin G product, Gammaplex®, in primary immunodeficiency diseases

This open-label multi-centre study evaluated a new intravenous immunoglobulin, Gammaplex®, in the treatment of 50 patients with primary immunodeficiency and significant hypogammglobulinaemia. Patients treated previously with other intravenous immunoglobulins received Gammaplex® on their same infusio...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Moy, J N, Scharenberg, A M, Stein, M R, Suez, D, Roberts, R L, Levy, R J, Ballow, M, Fasano, M B, Dash, C H, Leach, S J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2010
Gaiak:
Translational Studies
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3026554/
https://ncbi.nlm.nih.gov/pubmed/21070209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2010.04247.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak